SCHEMBL14318935

SCHEMBL14318935

CC12CCC(=O)C=C1C[C@@H](C=O)C1C2[C@H](O)CC2(C)C1CC[C@@]21CCC(=O)O1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 5/20 0.55
▸ LMNA P02545 4/20 0.55
▸ PGR P06401 4/20 0.55
▸ CYP3A4 P08684 4/20 0.55
▸ NR3C2 P08235 3/20 0.55
▸ AR P10275 3/20 0.55
▸ HIF1A Q16665 3/20 0.55
▸ CHRM2 P08172 2/20 0.55
▸ OPRK1 P41145 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ ABCB11 O95342 1/20 0.55
▸ ESR1 P03372 1/20 0.55
▸ ABCB1 P08183 1/20 0.55
▸ ADRA1A P35348 1/20 0.55
▸ HTR2B P41595 1/20 0.55
▸ ESR2 Q92731 1/20 0.55
▸ SLC47A1 Q96FL8 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ MAPT P10636 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14318934 0.88 NR3C1 (0.58) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14108203 0.87 NR3C1 (0.55) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14308728 0.86 CYP3A4 (0.67) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14284950 0.85 NR3C1 (0.58) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14284933 0.85 NR3C1 (0.54) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14592565 0.84 HIF1A (0.54) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14084961 0.84 NR3C1 (0.70) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14450055 0.84 NR3C1 (0.70) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14565704 0.84 NR3C1 (0.70) NR3C1LMNAPGRCYP3A4NR3C2
SCHEMBL14508986 0.84 NR3C1 (0.70) NR3C1LMNAPGRCYP3A4NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein NG JOHN S 2008-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein CYP4A11, CYP11B1, CYP17A1 NR3C1 89/4885LMNA 1449/4885PGR 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback